Cargando…
Treatment of Irritability in Huntington’s Disease
Irritability is a common neuropsychiatric feature of Huntington’s disease (HD), with prevalences varying from 38% to 73%. Similar prevalences of irritability are reported in other neurodegenerative disorders and traumatic brain injury, especially when the frontal lobe is involved. Before therapeutic...
Autor principal: | van Duijn, Erik |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2918785/ https://www.ncbi.nlm.nih.gov/pubmed/20730109 http://dx.doi.org/10.1007/s11940-010-0088-3 |
Ejemplares similares
-
An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease
por: Groves, Mark, et al.
Publicado: (2011) -
A RARE CASE OF PULMONARY DISEASE IN IGG4-RELATED DISEASE: COVID-19 MIMIC
por: CHAO, C., et al.
Publicado: (2022) -
An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington’s Disease
por: Anderson, Karen, et al.
Publicado: (2011) -
IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE (IMCD) AS A MANIFESTATION OF POST-COVID-19 INFLAMMATORY SYNDROME
por: YAN, CHRIS, et al.
Publicado: (2022) -
A CASE OF ANTISYNTHETASE SYNDROME: THE IMPORTANCE OF HISTORY IN DISTINGUISHING ETIOLOGY OF INTERSTITIAL LUNG DISEASE IN A COVID-19 WORLD
por: SIMON, ALYSSA N., et al.
Publicado: (2022)